# MDMA-assisted Therapy for Fibromyalgia

> **NCT06066853** · EARLY_PHASE1 · RECRUITING · sponsor: **Spaulding Rehabilitation Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** MDMA

## Key facts

- **NCT ID:** NCT06066853
- **Lead sponsor:** Spaulding Rehabilitation Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06066853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06066853, "MDMA-assisted Therapy for Fibromyalgia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06066853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*